|
1
|
Alberti KG, Zimmet P and Shaw J: IDF
Epidemiology Task Force Consensus Group: The metabolic syndrome-a
new worldwide definition. Lancet. 366:1059–1062. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kannel WB and Cobb J: Left ventricular
hypertrophy and mortality-results from the framingham study.
Cardiology. 81:291–298. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chae CU, Pfeffer MA, Glynn RJ, Mitchell
GF, Taylor JO and Hennekens CH: Increased pulse pressure and risk
of heart failure in the elderly. JAMA. 281:634–639. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reaven GM: Role of insulin resistance in
human disease (syndrome X): An expanded definition. Annu Rev Med.
44:121–131. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meshkani R and Adeli K: Hepatic insulin
resistance, metabolic syndrome and cardiovascular disease. Clin
Biochem. 42:1331–1346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Torfgård KE and Ahlner J: Mechanisms of
action of nitrates. Cardiovasc Drugs Ther. 8:701–717. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boyd CS and Cadenas E: Nitric oxide and
cell signaling pathways in mitochondrial-dependent apoptosis. Biol
Chem. 383:411–423. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang X, Diao Y, Liu Y, Gao N, Gao D, Wan
Y, Zhong J and Jin G: Synergistic apoptosis-inducing effect of
aspirin and isosorbide mononitrate on human colon cancer cells. Mol
Med Rep. 12:4750–4758. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
National Research Council: Guide for the
Care and Use of Laboratory Animals. National Academy Press;
Washington, DC: pp. 1401996
|
|
10
|
Frustaci A, Kajstura J, Chimenti C,
Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B and Anversa P:
Myocardial cell death in human diabetes. Circ Res. 87:1123–1132.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sam F, Sawyer DB, Chang DL, Eberli FR,
Ngoy S, Jain M, Amin J, Apstein CS and Colucci WS: Progressive left
ventricular remodeling and apoptosis late after myocardial
infarction in mouse heart. Am J Physiol Heart Circ Physiol.
279:H422–H428. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen HI and Hu CT: Endogenous nitric oxide
on arterial hemodynamics: A comparison between normotensive and
hypertensive rats. Am J Physiol. 273:H1816–H1823. 1997.PubMed/NCBI
|
|
13
|
Thadani U and Lipicky RJ: Short and
long-acting oral nitrates for stable angina pectoris. Cardiovasc
Drugs Ther. 8:611–623. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu CC and Yen MH: Higher level of plasma
nitric oxide in spontaneously hypertensive rats. Am J Hypertens.
12:476–482. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Förstermann U and Sessa WC: Nitric oxide
synthases: Regulation and function. Eur Heart J. 33(829–837):
837a–837d. 2012.
|
|
16
|
Hua W, Chen Q, Gong F, Xie C, Zhou S and
Gao L: Cardioprotection of H2S by downregulating iNOS and
upregulating HO-1 expression in mice with CVB3-induced myocarditis.
Life Sci. 93:949–954. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li YC, Luo Q, Ge LS, Chen YH, Zhou ND,
Zhang T, Guan XQ and Lin JF: Ivabradine inhibits the production of
proinflammatory cytokines and inducible nitric oxide synthase in
acute coxsackievirus B3-induced myocarditis. Biochem Biophys Res
Commun. 431:450–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brüne B: Nitric oxide: NO apoptosis or
turning it ON? Cell Death Differ. 10:864–869. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dobrin JS and Lebeche D: Diabetic
cardiomyopathy: Signaling defects and therapeutic approaches.
Expert Rev Cardiovasc Ther. 8:373–391. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boudina S and Abel ED: Diabetic
cardiomyopathy, causes and effects. Rev Endocr Metab Disord.
11:31–39. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Khavandi K, Khavandi A, Asghar O,
Greenstein A, Withers S, Heagerty AM and Malik RA: Diabetic
cardiomyopathy-a distinct disease? Best Pract Res Clin Endocrinol
Metab. 23:347–360. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Singh S, Duggal J, Khosla N and Arora R:
Screening guidelines for coronary heart disease in diabetes:
Current recommendations. J Cardiometab Syndr. 4:107–112. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carvalho-Filho MA, Ueno M, Carvalheira JB,
Velloso LA and Saad MJ: Targeted disruption of iNOS prevents
LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin
resistance in muscle of mice. Am J Physiol Endocrinol Metab.
291:E476–E482. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carvalho-Filho MA, Ueno M, Hirabara SM,
Seabra AB, Carvalheira JB, de Oliveira MG, Velloso LA, Curi R and
Saad MJ: S-nitrosation of the insulin receptor, insulin receptor
substrate 1, and protein kinase B/Akt: A novel mechanism of insulin
resistance. Diabetes. 54:959–967. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Perreault M and Marette A: Targeted
disruption of inducible nitric oxide synthase protects against
obesity-linked insulin resistance in muscle. Nat Med. 7:1138–1143.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fritz M and Rinaldi G: Blood pressure
measurement with the tail-cuff method in Wistar and spontaneously
hypertensive rats: Influence of adrenergic- and nitric
oxide-mediated vasomotion. J Pharmacol Toxicol Methods. 58:215–221.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lai J, Wu B, Sun J, Shang Y and Zhu J:
Long-term isosorbide mononitrate treatment impairs endothelial
function in patients with coronary artery disease. Coron Artery
Dis. 24:566–571. 2013. View Article : Google Scholar : PubMed/NCBI
|
